The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized, open-label study comparing the efficacy and safety of AG-221 vs conventional care regimens (CCR) in older patients with advanced acute myeloid leukemia (AML) with isocitrate dehydrogenase (IDH)-2 mutations in relapse or refractory to multiple prior treatments: the IDHENTIFY trial.
 
Martin S. Tallman
Research Funding - BiolineRx; Boehringer Ingelheim; Epizyme
 
Robert D. Knight
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Axel G. Glasmacher
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Hartmut Dohner
Consulting or Advisory Role - Agios; Astex Pharmaceuticals; Celator; Celgene; GlaxoSmithKline; Novartis; Roche/Genentech; Seagen; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Celgene